by John Conrad | Sep 25, 2024 | NewsBrief
PCI Pharma Services is set to significantly expand its presence in Rockford, Illinois, as part of a broader $365 million investment across its U.S. and European operations. The contract development and manufacturing organization (CDMO) announced on Tuesday, September...
by John Conrad | Sep 24, 2024 | Member News, NewsBrief
Swedish rare disease specialist Immedica Pharma AB continues to strengthen its position in the U.S. market with two significant announcements this month. Chicago Becomes U.S. Base for Global Rare Disease Company On September 9th, Immedica revealed plans to establish...
by John Conrad | Sep 19, 2024 | NewsBrief
Syntax Bio has launched with $15 million in funding from notable investors, including Astellas Venture Management LLC and Illumina Ventures. The Chicago-based startup is pioneering a novel approach to cell therapy with its Cellgorithm platform. Syntax Bio’s...
by John Conrad | Sep 11, 2024 | NewsBrief
In a significant development for the healthcare industry, Chicago-based 32 Biosciences has announced its emergence from stealth mode, unveiling a groundbreaking approach to gut microbiome medicine. The company, whose name is pronounced “Three Squared...
by John Conrad | Sep 9, 2024 | NewsBrief
Immedica Pharma AB, a Stockholm-based pharmaceutical company specializing in rare and severe diseases, has announced its expansion into the United States market. The company has established Immedica Pharma US Inc., with headquarters in Chicago, marking a significant...
by John Conrad | Sep 3, 2024 | NewsBrief
PitchBook, a leading financial data and software company, has released its highly anticipated 2024 rankings of the Top 100 colleges for startup founders. This annual list, which has become a benchmark in the entrepreneurial ecosystem, evaluates universities based on...
